Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

NCT01782963 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Massachusetts General Hospital